-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express CheckoutTenofovir Disoproxil Fumarate Emtricitabine and Efavirenz Tablets
Common Disease Medicine Contact Seller for Price -
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
Express Checkout
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nimesulide 100 mg + Cetirizine 5 mg + Phenylepherin 10 mg tablet
Common Disease Medicine Contact Seller for Price -
-
-
Ketoconazole 2.0% w/w +Iodochlorohydroxy quinoline 1.0% w/w + Tolnaftate 1.0% w/w + Gentamicin Sulphate 0.10% w/w + Clobetasol Propionate 0.05% w/w
Common Disease Medicine Contact Seller for Price -
Sertaconazole Nitrate 2.0% w/w + Beclomethasone Dipropionate 0.025% w/w + Benzyl Alcohol 1.0% w/w
Common Disease Medicine Contact Seller for Price -
Lidocaine Hydrochloride 2.5% w/w + Prilocaine 2.5% w/w
Common Disease Medicine Contact Seller for Price -
Clobetasol Propionate 0.05 % w/w + Neomycin Sulphate 0.5% w/w + Tolnaftate 1.0% w/w + Quiniodochloro 1.0% w/w + Clotrimazole 1.0% w/w
Common Disease Medicine Contact Seller for Price -
Ketoconazole 2.0% w/w + Clobetasol Propionate 0.05% w/w + Neomycin Sulphate 0.10% w/w
Common Disease Medicine Contact Seller for Price -
-
-
-
-
-
Ciclopirox olamine 1.0% w/w Excipients In a cream base
Common Disease Medicine Contact Seller for Price -
Halobetasol Propionate 0.05% w/v Excipients in a lotion base
Common Disease Medicine Contact Seller for Price -
Halobetasol Propionate 0.05% w/v + Salicylic Acid 3.0% w/v Excipients in a lotion base
Common Disease Medicine Contact Seller for Price -
Mometasone Furoate 0.1% w/w + Salicylic Acid 5.0% w/w Ointment
Common Disease Medicine Contact Seller for Price -
Ornidazole Gel 1.0% w/w + Chlorhexidine Gluconate Solution 0.25% w/w
Common Disease Medicine Contact Seller for Price -
Betamethasone Dipropionate 0.064% w/w+ Salicylic Acid 3.0% w/w Lotion
Common Disease Medicine Contact Seller for Price -
-
We are upgrading our infrastructure for a faster experience. We appreciate your patience in the meantime.
